Daniel Munoz Espin Interview
We had the chance to meet Dr. Daniel Munoz Espin, the Oncology Department of Cambridge University, during the Fourth Eurosymposium on Healthy Ageing, which took place in Brussels, Belgium, last November.
Dr. Munoz-Espin earned his PhD at the Autonomous University of Madrid in Spain. He worked with the viral DNA replication team at the Centre of Molecular Biology Severo Ochoa under the supervision of Dr. Margarita Salis, one of Spain’s most celebrated scientists. His postdoctoral work resulted in a patent and several publications on DNA replication. He then joined the Centro Nacional de Investigaciones Oncologicas (CNIO), the Spanish National Centre for Cancer Research. The research that Dr. Munoz-Espin conducted during this time demonstrated how cellular senescence doesn’t play a role just in aging and cancer but also in normal embryonic development, where it contributes to the shaping of our bodies–a process that was termed \”developmentally-programmed senescence\”, whose concept was very favorably received by the scientific community.
Dr. Munoz-Espin is currently Principal Investigator of the Cancer Early Detection Programme in the Department of Oncology at Cambridge University. With his team, he developed a new method to target senescent cell, which was published in EMBO Molecular Medicine. Dr. Munoz-Espin spoke about this topic at EHA2018, and it was one of many that he discussed during the interview.
Source:
https://www.leafscience.org/an-interview-with-daniel-munoz-espin/
